Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
Credit agrmnt [a]
Acq. announced
Appointed director
|
|
SEROLOGICALS CORP (SERO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/23/2004 |
8-K
| Asset disposition|
Docs:
|
"Exchange Agreement, between Life Therapeutics Limited and Serologicals Finance Company",
"Promissory Note, made by Life Therapeutics Limited, Life Gels, Inc., Life Therapeutics Plasma Holdings, Inc., LifeSera, Inc., LifeSera Nevada, Inc., LifeSera Business Trust, LifeSera Investments, LLC, LifeSera Management Partnership, LP, and Allegheny Biologicals, Inc. to Serologicals Finance Company",
"Mutual Release Agreement, by and among Life Therapeutics Limited, Life Gels, Inc., Life Therapeutics Plasma Holdings, Inc., LifeSera, Inc., LifeSera Nevada, Inc., LifeSera Business Trust, LifeSera Investments, LLC, LifeSera Management Partnership, LP, and Allegheny Biologicals, Inc., on the one hand, and Serologicals Corporation and Serologicals Finance Company, on the other hand",
"Opinion of King & Spalding LLP",
"SEROLOGICALS ANNOUNCES CLOSING OF PUBLIC OFFERING" |
|
|
|